Showing results (331-340 of 513) with videos related to
Sort By:
Pageof 52
Journal of Drugs in Dermatology : JDD|February 6, 2025
Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc AnalysesKenneth B Gordon, Joseph F Merola, Peter Foley, et al.RMD Open|September 23, 2024
Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studiesM Elaine Husni, Philip J Mease, Joseph F Merola, et al.The Journal of Dermatological Treatment|May 26, 2018
Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severityMwangi J Murage, Amanda Anderson, Deborah Casso, et al.Plos One|February 29, 2020
A Bayesian approach for detecting a disease that is not being modeledJohn M Aronis, Jeffrey P Ferraro, Per H Gesteland, et al.American Heart Journal|September 1, 1988
Regional coronary hemodynamic effects of diltiazem in manC Vigorito, A Giordano, L De Caprio, et al.Scandinavian Journal of Infectious Diseases|January 1, 1995
Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in ItalyA Mele, R Corona, M E Tosti, et al.International Journal of Cancer|February 20, 1991
EGF in breast cyst fluid: relationships with intracystic androgens, estradiol and progesteroneF Boccardo, R Torrisi, S Zanardi, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 19, 2020
Coronary microvascular dysfunction in patients with psoriasisBrittany Weber, Lourdes M Perez-Chada, Sanjay Divakaran, et al.Rheumatology (Oxford, England)|February 11, 2024
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritisDennis McGonagle, Arthur Kavanaugh, Iain B McInnes, et al.The British Journal of Dermatology|April 29, 2021
Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy studyA B Gottlieb, J F Merola, K Reich, et al.Pageof 52